Abstract Details
|
PRESENTER |
No disclosure on file |
| Heidi J. Crayton, MD | The institution of Dr. Crayton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bristol Myers Squibb. The institution of Dr. Crayton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Crayton has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for EMD Serono. The institution of Dr. Crayton has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for BMS. The institution of Dr. Crayton has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Crayton has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sandoz. The institution of Dr. Crayton has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for TG Therapeutics. The institution of Dr. Crayton has received research support from EMD Serono. The institution of Dr. Crayton has received research support from Sanofi. The institution of Dr. Crayton has received research support from Atara. |
| John D. Fisk, PhD (Nova Scotia Health) | The institution of Dr. Fisk has received research support from Canadian Institutes of Health Research. The institution of Dr. Fisk has received research support from Multiple Sclerosis Society of Canada. Dr. Fisk has received publishing royalties from a publication relating to health care. |
| Scott Patten, PhD (Univ of Calgary, Community Health Sciences) | Dr. Patten has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Canadian Psychiatric Association. Dr. Patten has received publishing royalties from a publication relating to health care. |
| Helen Tremlett, PhD, BPharm (University of British Columbia) | Dr. Tremlett has nothing to disclose. |
| No disclosure on file | |
| Sharon A. Warren, PhD (University of Alberta) | No disclosure on file |
| Kyla A. McKay, PhD (Karolinska Institutet) | Dr. McKay has received research support from Canadian Institutes of Health Research. Dr. McKay has received research support from Swedish Research Council for Health, Working Life, and Welfare. Dr. McKay has received research support from ECTRIMS. |
| No disclosure on file | |
| Ruth-Ann Marrie, MD, PhD (University of Manitoba) | The institution of Dr. Marrie has received research support from CIHR. The institution of Dr. Marrie has received research support from MS Canada. The institution of Dr. Marrie has received research support from National MS Society. The institution of Dr. Marrie has received research support from Crohn's and Colitis Canada. The institution of Dr. Marrie has received research support from US Department of Defense. The institution of Dr. Marrie has received research support from The Arthritis Society. The institution of Dr. Marrie has received research support from CMSC. |